BiomX (PHGE) News Today $0.62 +0.05 (+8.89%) (As of 12/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartFinancialsHeadlinesInsider TradesOwnershipSEC Filings All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period BiomX Inc. Regains Compliance with NYSE American Listing StandardsDecember 19 at 4:13 AM | americanbankingnews.comBiomX regains compliance with NYSE American continued listing standardsDecember 17, 2024 | markets.businessinsider.comBiomX shares hold Buy rating from H.C. Wainwright on Q3 resultsNovember 17, 2024 | uk.investing.comBiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program UpdatesNovember 14, 2024 | globenewswire.comBiomX to Host Third Quarter 2024 Financial Results Conference Call and Webcast on November 14, 2024November 12, 2024 | globenewswire.comBiomX (NYSEMKT:PHGE) Trading Down 2.3% - Here's WhyBiomX (NYSEMKT:PHGE) Stock Price Down 2.3% - Should You Sell?October 23, 2024 | marketbeat.comBiomX Announces a Mandatory Unit SeparationOctober 15, 2024 | globenewswire.comBiomX to Provide Latest Update on Positive Phase 1b/2a Clinical Trial Data for BX004 at the North American Cystic Fibrosis ConferenceSeptember 18, 2024 | globenewswire.comBiomX (NYSEMKT:PHGE) Shares Down 5.4% BiomX (NYSEMKT:PHGE) Stock Price Down 5.4%September 10, 2024 | marketbeat.comBiomX to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 4, 2024 | globenewswire.comPHGE-U,0P0001F68H,0 (PHGE-U)August 26, 2024 | nz.finance.yahoo.comUPDATE ON UNITS - BiomX Inc. Announces 1-for-10 Reverse Stock SplitAugust 16, 2024 | globenewswire.comBiomX Inc. (PHGE) Q2 2024 Earnings Call TranscriptAugust 15, 2024 | seekingalpha.comVinFast Returns to Canadian National Exhibition 2024August 15, 2024 | uk.finance.yahoo.comBiomX Sets One-for-ten Reverse Stock SplitAugust 15, 2024 | markets.businessinsider.comBiomX Reports Second Quarter 2024 Financial Results and Provides Business and Program UpdatesAugust 15, 2024 | globenewswire.comBiomX Inc. Announces 1-for-10 Reverse Stock SplitAugust 15, 2024 | globenewswire.comBiomX to Host Second Quarter 2024 Financial Results Conference Call and Webcast on August 15, 2024August 8, 2024 | globenewswire.comBiomX Inc. Announces NYSE American Acceptance of Plan to Regain Listing ComplianceJuly 29, 2024 | globenewswire.comBiomX Inc. Announces Stockholder Approval for Conversion of Outstanding Series X Convertible Preferred Stock to Common StockJuly 10, 2024 | globenewswire.comBiomX Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing StandardsMay 30, 2024 | globenewswire.comBiomX to Present Phase 1b/2a Clinical Trial Data for BX004 at the 47th European Cystic Fibrosis Conference and at ASM Microbe 2024May 30, 2024 | globenewswire.comBiomX Reports First Quarter 2024 Financial Results and Provides Business and Program UpdatesMay 21, 2024 | globenewswire.comBiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024May 15, 2024 | globenewswire.comBiomX to Present at the 2024 RBC Capital Markets Global Healthcare ConferenceMay 14, 2024 | finance.yahoo.comBiomx Inc (PHGE_u)April 25, 2024 | investing.comBiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)April 23, 2024 | globenewswire.comBiomX expands board with new director and audit chairApril 19, 2024 | investing.comBiomX Announces the Appointment of Susan Blum to its Board of DirectorsApril 18, 2024 | globenewswire.comBiomX receives going concern note from auditorsApril 6, 2024 | uk.investing.comBiomX Announces Compliance with NYSE Guidelines on Audit Opinion DisclosureApril 4, 2024 | globenewswire.comU.S. Futures Dip in Pre-Market, May WTI and June Brent Crude Prices Edge HigherApril 3, 2024 | msn.comBiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateApril 3, 2024 | globenewswire.comBiomX to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast on April 3rd, 2024March 27, 2024 | globenewswire.comBiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million FinancingMarch 18, 2024 | globenewswire.comBiomX Buy Rating Justified by Merger Synergy, Enhanced Financial Stability, and Promising Clinical TrialsMarch 7, 2024 | markets.businessinsider.comBiomX Acquisition and Clinical Trial Successes Prompt Buy Rating by Analyst Michael HigginsMarch 7, 2024 | markets.businessinsider.comShareholder Alert: Ademi LLP investigates the transaction between BiomX Inc. and Adaptive Phage TherapeuticsMarch 7, 2024 | prnewswire.comWhy BiomX Stock Is Surging TodayMarch 6, 2024 | msn.comWhy Is BiomX (PHGE) Stock Up 147% Today?March 6, 2024 | investorplace.comBiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50 Million FinancingMarch 6, 2024 | globenewswire.comNanoViricides reports positive safety results for COVID drug candidateJanuary 29, 2024 | msn.comBiomX GAAP EPS of -$0.13 misses by $0.03November 14, 2023 | msn.comBiomX Reports Third Quarter 2023 Financial Results and Provides Business UpdateNovember 14, 2023 | finance.yahoo.comMustang Bio stock jumps 10% on FDA acceptance of new drug applicationOctober 26, 2023 | msn.comHC Wainwright & Co. Reiterates BiomX (PHGE) Buy RecommendationAugust 9, 2023 | msn.comBiomX GAAP EPS of -$0.12 beats by $0.02August 9, 2023 | msn.comPHGE - BiomX Inc.July 19, 2023 | uk.finance.yahoo.comNYSE American to Commence Delisting Proceedings with Respect to the Warrants of BiomX Inc. (PHGE.WS)June 2, 2023 | finance.yahoo.comBiomX to Present Part 1 Data from Phase 1b/2a Study Evaluating BX004 for the Treatment of Chronic Pseudomonas aeruginosa Pulmonary Infections in Patients with Cystic Fibrosis During Late-Breaking Science Session at the 46th European Cystic Fibrosis Conference (ECFC)May 31, 2023 | finance.yahoo.com Get BiomX News Delivered to You Automatically Sign up to receive the latest news and ratings for PHGE and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now PHGE Media Mentions By Week PHGE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PHGE News Sentiment▼0.000.60▲Average Medical News Sentiment PHGE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PHGE Articles This Week▼20▲PHGE Articles Average Week Get BiomX News Delivered to You Automatically Sign up to receive the latest news and ratings for PHGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Kezar Life Sciences News MariMed News Omega Therapeutics News Exicure News Ayr Wellness News Atlantic Coastal Acquisition Corp. II News Estrella Immunopharma News Aileron Therapeutics News Virios Therapeutics News Cardio Diagnostics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEMKT:PHGE) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BiomX Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BiomX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PHGE Stock Alerts